BRAF V600E-mutated combined large cell neuroendocrine carcinoma and adenocarcinoma responding to targeted therapy

We present a case of combined large cell neuroendocrine carcinoma (LCNEC), harbouring a BRAF V600E mutation, which significantly benefited from BRAF-targeted therapy. A 57-year-old woman was referred to our hospital for headache and vomiting. A head MRI showed a large tumour in her brain, and a whol...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakamoto, Tomohiro, Arai, Katsunori, Makishima, Karen, Yamasaki, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719127/
https://www.ncbi.nlm.nih.gov/pubmed/34969785
http://dx.doi.org/10.1136/bcr-2021-243295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719127/
https://www.ncbi.nlm.nih.gov/pubmed/34969785
http://dx.doi.org/10.1136/bcr-2021-243295

Ejemplares similares